Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Int Arch Allergy Immunol

Retrieve available abstracts of 38 articles:
HTML format

Single Articles

    September 2022
  1. DU L, Xu C, Shi J, Tang L, et al
    Elevated CXCL14 in Induced Sputum Was Associated with Eosinophilic Inflammation and Airway Obstruction in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Sep 5:1-10. doi: 10.1159/000526367.
    PubMed     Abstract available

    August 2022
  2. ARSLAN B, Pacaci Cetin G, Turk M, Gulmez I, et al
    Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
    Int Arch Allergy Immunol. 2022 Aug 2:1-7. doi: 10.1159/000525723.
    PubMed     Abstract available

    June 2022
  3. YANG Y, Huang G, Xu Q, Zhao G, et al
    miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages.
    Int Arch Allergy Immunol. 2022 Jun 3:1-12. doi: 10.1159/000524718.
    PubMed     Abstract available

    May 2022
  4. ZONG W, Liang Y, Mo Y
    Increased SERPINB10 Expression in Induced Sputum Was Associated with Airway Type 2 Inflammation in Asthma.
    Int Arch Allergy Immunol. 2022 May 6:1-7. doi: 10.1159/000524613.
    PubMed     Abstract available

    April 2022
  5. CHEN L, Wang W, Leng Q, Cong L, et al
    Associations of the Methylation Levels of NFAT5, PVT1, RPS6KA1, and MIB1 with Steroid-Resistant Asthma.
    Int Arch Allergy Immunol. 2022 Apr 13:1-12. doi: 10.1159/000524080.
    PubMed     Abstract available

    March 2022
  6. HUANG QP, Xie ZF, Huang J
    Assessment of the Association between Genetic Polymorphisms in the CHI3L1 Gene and Asthma Risk.
    Int Arch Allergy Immunol. 2022 Mar 25:1-12. doi: 10.1159/000522393.
    PubMed     Abstract available

    February 2022
  7. ZONG W, Mo Y, Liang Y
    Correlation between Increased Monocyte Chemotactic Protein 1 Level and Lung Function in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 23:1-9. doi: 10.1159/000521946.
    PubMed     Abstract available

  8. SCHIFFER M, Peters K, Peters M
    Comparison of Airway Remodeling in Two Different Endotypes of Allergic Asthma.
    Int Arch Allergy Immunol. 2022 Feb 22:1-12. doi: 10.1159/000522189.
    PubMed     Abstract available

  9. XU C, Du L, Zeng Z, Chen F, et al
    Elevated CEACAM5 Levels in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 16:1-9. doi: 10.1159/000521754.
    PubMed     Abstract available

  10. FENG Y, Zhang S, Shang Y, Chen N, et al
    The Use of Exercise Challenge Testing and Fractional Exhaled Nitric Oxide in Diagnosis of Chest Tightness Variant Asthma in Children.
    Int Arch Allergy Immunol. 2022 Feb 14:1-8. doi: 10.1159/000522062.
    PubMed     Abstract available

  11. RYDELL N, Nagao M, Moverare R, Ekoff H, et al
    Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma.
    Int Arch Allergy Immunol. 2022 Feb 10:1-9. doi: 10.1159/000521890.
    PubMed     Abstract available

    January 2022
  12. TAKEUCHI H, Takanashi S, Hasan SMT, Hore SK, et al
    Anti-Ascaris IgE as a Risk Factor for Asthma Symptoms among 5-Year-Old Children in Rural Bangladesh with Even Decreased Ascaris Infection Prevalence.
    Int Arch Allergy Immunol. 2022 Jan 31:1-11. doi: 10.1159/000521717.
    PubMed     Abstract available

  13. KAMA Y, Yamada Y, Koike T, Suzuki K, et al
    Antibiotic Treatments Prolong the Wheezing Period in Acute Exacerbation of Childhood Bronchial Asthma.
    Int Arch Allergy Immunol. 2022 Jan 24:1-11. doi: 10.1159/000521192.
    PubMed     Abstract available

  14. FILIOU A, Holmdahl I, Asarnoj A, van Hage M, et al
    Development of Sensitization to Multiple Allergen Molecules from Preschool to School Age Is Related to Asthma.
    Int Arch Allergy Immunol. 2022 Jan 18:1-12. doi: 10.1159/000521324.
    PubMed     Abstract available

  15. FUKUMITSU K, Nishiyama H, Kanemitsu Y, Takeda N, et al
    Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naive Asthma.
    Int Arch Allergy Immunol. 2022 Jan 14:1-11. doi: 10.1159/000520508.
    PubMed     Abstract available

  16. SOTO A, Perrone Sibilia M, Sanchez VR, Arcon N, et al
    Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness.
    Int Arch Allergy Immunol. 2022 Jan 11:1-8. doi: 10.1159/000520796.
    PubMed     Abstract available

  17. MING X, Yu X, Li J, Wang J, et al
    Salidroside Attenuates Airway Inflammation and Remodeling via the miR-323-3p/SOCS5 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:424-434.
    PubMed     Abstract available

  18. WANG Z, Zhang J, Yan H, Dong L, et al
    Kawasaki Disease and Atopic Diseases: A Systematic Review and Meta-Analysis of Observational Studies.
    Int Arch Allergy Immunol. 2022;183:389-397.
    PubMed     Abstract available

  19. YOOMA P, Manuyakorn W, Sawatchai A, Jotikasthira W, et al
    Serum Periostin Predicts Wheezing Exacerbation: A Prospective Study in Preschool Children with Recurrent Wheezing.
    Int Arch Allergy Immunol. 2022;183:271-278.
    PubMed     Abstract available

  20. LIU Y, Zhang M, Zhang H, Qian X, et al
    Anthocyanins Inhibit Airway Inflammation by Downregulating the NF-kappaB Pathway via the miR-138-5p/SIRT1 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:539-551.
    PubMed     Abstract available

  21. LUAN X, Cui C, Jiang J, Wang C, et al
    Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3beta Signaling Pathway.
    Int Arch Allergy Immunol. 2022;183:326-336.
    PubMed     Abstract available

  22. ZHANG Y, Yan L, Yang J, Li X, et al
    Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis.
    Int Arch Allergy Immunol. 2022;183:785-795.
    PubMed     Abstract available

  23. PUXEDDU I, Petrelli F, Cristofani-Mencacci L, Scarano M, et al
    Component-Resolved Diagnosis for Endotyping Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:770-777.
    PubMed     Abstract available

  24. LOPEZ-RODRIGUEZ R, Rial MJ, Esteban-Gorgojo I, Veleiro Perez B, et al
    Serodominance Profile in a Dust Mite Complex Region.
    Int Arch Allergy Immunol. 2022;183:843-851.
    PubMed     Abstract available

  25. HAN J, Wang W, Zhu Z, Wang L, et al
    Profile of Tissue Immunoglobulin E in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:835-842.
    PubMed     Abstract available

    December 2021
    Current Recommendations on the Management of Pediatric Asthma and Allergic Rhinitis during the COVID-19 Pandemic versus Real-Life Practice.
    Int Arch Allergy Immunol. 2021 Dec 28:1-8. doi: 10.1159/000521117.
    PubMed     Abstract available

  27. HE R, Chen Y, Chen X, Yuan B, et al
    Mechanism of miR-181a-5p in Regulatory T/T-Helper 17 Immune Imbalance and Asthma Development in Mice with Allergic Rhinitis.
    Int Arch Allergy Immunol. 2021 Dec 23:1-14. doi: 10.1159/000519703.
    PubMed     Abstract available

  28. OZDEL OZTURK B, Yavuz Z, Eraslan D, Mungan D, et al
    Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
    Int Arch Allergy Immunol. 2021 Dec 14:1-13. doi: 10.1159/000520725.
    PubMed     Abstract available

  29. REINSBERG M, Siebert S, Dreher C, Bogs T, et al
    Predictors of Airway Hyperresponsiveness in Symptomatic Children with Normal Spirometry and Suspicious of Possible Asthma.
    Int Arch Allergy Immunol. 2021 Dec 10:1-9. doi: 10.1159/000520670.
    PubMed     Abstract available

    October 2021
  30. TORRE E, Sola D, Caramaschi A, Mignone F, et al
    A Pilot Study on Clinical Scores, Immune Cell Modulation, and Microbiota Composition in Allergic Patients with Rhinitis and Asthma Treated with a Probiotic Preparation.
    Int Arch Allergy Immunol. 2021 Oct 21:1-15. doi: 10.1159/000518952.
    PubMed     Abstract available

  31. ALABED M, Sultana Shaik A, Saheb Sharif-Askari N, Saheb Sharif-Askari F, et al
    Enhanced Infiltration of Central Memory T Cells to the Lung Tissue during Allergic Lung Inflammation.
    Int Arch Allergy Immunol. 2021 Oct 20:1-15. doi: 10.1159/000518835.
    PubMed     Abstract available

  32. KOYA T, Sakai N, Sasaki T, Shinbori K, et al
    Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
    Int Arch Allergy Immunol. 2021 Oct 15:1-9. doi: 10.1159/000519296.
    PubMed     Abstract available

  33. PAN HH, Ko JL, Wu CT, Sun HL, et al
    Effect of the Fungal Immunomodulatory Protein FIP-fve in the Neutrophilic Asthma Animal Model.
    Int Arch Allergy Immunol. 2021 Oct 14:1-12. doi: 10.1159/000517184.
    PubMed     Abstract available

    September 2021
  34. INOUE H, Akimoto K, Ikeda H, Sato H, et al
    Comprehensive Gene Expression Signature Using RNA-Seq in Airways of Mouse Model of Severe Asthma with Fungal Sensitization.
    Int Arch Allergy Immunol. 2021 Sep 29:1-11. doi: 10.1159/000519172.
    PubMed     Abstract available

  35. VENTURA MT, Giuliano AFM, Buquicchio R, Bedbrook A, et al
    Implementation of the MASK-Air(R) App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study.
    Int Arch Allergy Immunol. 2021 Sep 22:1-6. doi: 10.1159/000518032.
    PubMed     Abstract available

  36. SAHINER UM, Arik Yilmaz E, Fontanella S, Haider S, et al
    The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
    Int Arch Allergy Immunol. 2021 Sep 9:1-10. doi: 10.1159/000517865.
    PubMed     Abstract available

    January 2021
  37. METBULUT AP, Mustafaoglu O, Sen G, Kanik Yuksek S, et al
    Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.
    Int Arch Allergy Immunol. 2021;182:989-996.
    PubMed     Abstract available

  38. HE Y, Liu J, Zhao D, Zhang S, et al
    The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
    Int Arch Allergy Immunol. 2021;182:1231-1244.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.